Eqwal, a global O&P and healthcare provider, acquired Prestaco. What O&P consolidation looks like when it crosses borders.

Eqwal, a global healthcare and orthotics and prosthetics provider, has acquired Prestaco. Both companies are based in France. Prestaco, founded in 2018, provides medical equipment to healthcare facilities, medico-social organizations, and individuals. The O&P EDGE reported the deal.

The announcement is brief and the deal is narrow. It is also one more marker on a trend that is easier to see if you step back from the individual transaction.

What “medico-social organizations” means in this context

The phrase will be unfamiliar to readers outside the French healthcare system. In France, établissements médico-sociaux — medico-social institutions — are regulated facilities that sit between hospitals and community life. They include residential homes for adults with disabilities, vocational rehabilitation centers, supported-living arrangements for people with chronic conditions, and elder care settings. They are not hospitals, but they are not ordinary community practices either. They provide ongoing care to populations that include people with limb loss and limb difference who need durable equipment and fitting support on a continuous basis.

Prestaco’s stated work in this sector means it was supplying equipment into settings where residents may have little practical ability to shop around for another provider. That is worth noting not as a criticism of the acquisition, but as context for why who operates in these settings matters.

What this looks like as a pattern

We have tracked O&P consolidation in the United States through clinic network acquisitions over the past several months. The Eqwal/Prestaco deal is structurally different — it is a supply-side acquisition of a medical equipment distributor, not a clinic-level absorption — but the direction is familiar.

Large providers with global footprints are expanding their positions in the equipment supply chain. They are adding distributor relationships, facility contracts, and institutional accounts that create recurring, predictable revenue from populations with ongoing device and equipment needs. This is not a nefarious observation. Stable supply chains have genuine benefits for patients in institutional settings who need reliable access to consumables and replacement components.

What changes when ownership consolidates is who is making decisions about product selection, pricing, and service terms — and whether those decisions are made closer to or farther from the practitioner who knows the patient. That question does not resolve itself at the press-release stage.

What Eqwal is

The O&P EDGE describes Eqwal as a global healthcare and O&P provider. The company’s French headquarters and international framing suggest it operates across multiple European markets. What its clinical service model looks like at the practitioner level — whether it runs fitting services directly, manages distribution, or does both — is not detailed in the acquisition announcement. The acquisition of Prestaco, which serves both facility accounts and individual patients directly, implies it is expanding in both directions.

What this means if you are not in France

For the large majority of readers, this deal does not affect your care today. Its relevance is the pattern. The companies acquiring their way through O&P markets are building global positions, not just regional ones. International consolidation in medical equipment supply affects the range of products available in local markets over time, the pricing dynamics that practitioners navigate, and, eventually, the service model that determines what a fitting or a follow-up appointment looks like.

None of those effects arrive in a press release. They arrive slowly, in the form of product catalogs that look different, contracts that have changed, and waiting times that have shifted. The Eqwal/Prestaco transaction is one node in that process. How the European medico-social population it now serves is affected by the change in ownership is the longer question, and it is not one this announcement answers.

The next useful question — for researchers, journalists, and patient advocates tracking access in institutional care settings — is whether acquisition activity in this sector is accompanied by any regulatory or contractual framework requiring continuity of service, pricing transparency, or access standards for residents who cannot easily switch providers. In France, medico-social facilities operate under significant regulatory oversight. What that oversight covers, and what it leaves unaddressed at the supply-chain level, is where the practical answer to that question lives.

---

Amputee News does not provide individualized medical, legal, insurance, or device-fitting advice. References to companies and transactions are based on trade publication reporting and do not constitute endorsement of any company, product, or service. Medico-social services and their regulation vary by country and by specific facility type; contact local regulatory bodies or patient advocacy organizations for guidance in your jurisdiction.